Open AccessThe efficacy and toleration of celecoxib (Celebrex¯) in the treatment of osteoarthritis in Nigeria: a multicentre study
Author(s) -
SO Ogunlade,
LM Oginni,
HC Nwadiaro,
Oluwafemi Popoola,
UN Enweani,
B O Onabowale,
Dogunro As
Publication year - 2006
Publication title -
west african journal of medicine
Language(s) - English
Resource type - Journals
ISSN - 0189-160X
DOI - 10.4314/wajm.v24i3.28212
Subject(s) - medicine , celecoxib , osteoarthritis , adverse effect , arthritis , incidence (geometry) , population , alternative medicine , physics , environmental health , pathology , optics
Non-selective, non-steroidal anti-inflammatory drugs (NSAIDs) are effective in terms of pain relief and improving function in osteoarthritis. The advent of cyclooxygenase-2 (Cox-2) specific inhibitor, celecoxib, in the treatment of osteoarthritis has shown similar efficacy in relieving pain in osteoarthritis with low incidence of GI (Gastrointestinal) symptoms.